Vista do Neutrophil-to-lymphocyte ratio predicts long-term survival in early triple-negative breast cancer treated with neoadjuvant chemotherapy

Voltar aos Detalhes do Artigo Neutrophil-to-lymphocyte ratio predicts long-term survival in early triple-negative breast cancer treated with neoadjuvant chemotherapy Baixar Baixar PDF